VTv Total Current Liabilities from 2010 to 2024
| VTVT Stock | USD 15.51 0.09 0.58% |
Total Current Liabilities | First Reported 2013-12-31 | Previous Quarter 7 M | Current Value 6.4 M | Quarterly Volatility 16.2 M |
Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 27.56, Dividend Yield of 0.0 or Days Sales Outstanding of 2 K. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.
VTv | Total Current Liabilities |
Latest VTv Therapeutics' Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of vTv Therapeutics over the last few years. Total Current Liabilities is an item on VTv Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of vTv Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. VTv Therapeutics' Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
VTv Total Current Liabilities Regression Statistics
| Arithmetic Mean | 32,246,776 | |
| Geometric Mean | 19,076,540 | |
| Coefficient Of Variation | 108.35 | |
| Mean Deviation | 29,513,186 | |
| Median | 13,381,000 | |
| Standard Deviation | 34,940,992 | |
| Sample Variance | 1220.9T | |
| Range | 81.2M | |
| R-Value | (0.76) | |
| Mean Square Error | 550T | |
| R-Squared | 0.58 | |
| Significance | 0.0009 | |
| Slope | (5,958,763) | |
| Total Sum of Squares | 17092.2T |
VTv Total Current Liabilities History
About VTv Therapeutics Financial Statements
VTv Therapeutics shareholders use historical fundamental indicators, such as Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in VTv Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on VTv Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 10.6 M | 15 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VTv Stock Analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.